Alis Biosciences says its goal is to return to investors billions of dollars stuck on the balance sheets of “moribund” ...

Commissioner Martin Makary said the agency would, whenever possible, restrict drug company employees from participating as ...

The president’s executive order promising to lower pharmaceutical prices includes support for a fix long sought by the ...

The partners overcame an earlier rejection to win a seventh use for Dupixent, though some analysts are skeptical of its sales ...

The drug, orforglipron, helped people with diabetes reduce their blood sugar levels while spurring significant weight loss, ...

Drug company shares, which had sunk on comments by Trump that pharma duties would be coming soon, rallied along with the ...

Camzyos’ failure in a form of hypertrophic cardiomyopathy dampened its commercial outlook and spurred debate as to whether ...

The biotech is developing an experimental drug for the most common of a family of disorders all caused by errors in ...

The leaked budget draft, if approved by Congress, would reduce the FDA’s budget authority, indicating more disruption could ...

The startup, affiliated with China-based antibody designer Helixon Therapeutics, is developing bispecific drugs aimed at ...

Two studies published in Nature found stem cell-derived products can not only be safely transplanted into the brain, but also ...

Rare diseases, often referred to as orphan diseases, affect small patient populations, yet collectively they impact more than ...